- Area
- Pipeline Program
- Discovery
- Mouse、NHP POC
- IIT/IND
- Phase I
Metabolic/liver diseases
-
Hypercholesterolemia (EPI-001)
-
-
Hepatitis B, HBV (EPI-003)
-
-
Not disclosed
-
-
Not disclosed
-
-
Not disclosed
-
Ophthalmology disorders
-
Not disclosed
-
CNS disorders
-
Not disclosed
-
-
Not disclosed
-
Oncoimmunology
-
CAR-T
-
Partnership
-
-
- Therapeutic areas
- Pipeline projects
Metabolic/liver diseasesHypercholesterolemia (EPI-001)- Drug discovery
- POC (mice, NHP)
- IIT / IND
- Phase I
-
- Therapeutic areas
- Pipeline projects
Metabolic/liver diseasesHepatitis B, HBV (EPI-003)- Drug discovery
- POC (mice, NHP)
- IIT / IND
- Phase I
-
- Therapeutic areas
- Pipeline projects
Metabolic/liver diseasesNot disclosed- Drug discovery
- POC (mice, NHP)
- IIT / IND
- Phase I
-
- Therapeutic areas
- Pipeline projects
Metabolic/liver diseasesNot disclosed- Drug discovery
- POC (mice, NHP)
- IIT / IND
- Phase I
-
- Therapeutic areas
- Pipeline projects
Metabolic/liver diseasesNot disclosed- Drug discovery
- POC (mice, NHP)
- IIT / IND
- Phase I
-
- Therapeutic areas
- Pipeline projects
Ophthalmology disordersNot disclosed- Drug discovery
- POC (mice, NHP)
- IIT / IND
- Phase I
-
- Therapeutic areas
- Pipeline projects
CNS disordersNot disclosed- Drug discovery
- POC (mice, NHP)
- IIT / IND
- Phase I
-
- Therapeutic areas
- Pipeline projects
CNS disordersNot disclosed- Drug discovery
- POC (mice, NHP)
- IIT / IND
- Phase I
-
- Therapeutic areas
- Pipeline projects
OncoimmunologyCAR-T- Drug discovery
- POC (mice, NHP)
- IIT / IND
- Phase I
-
Partnership